TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$1.58
-0.03 (-1.86%)
As of Nov 12, 4:21 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,496.8% upside
Low Target $36.60
Average Target $41.03
High Target $68.97
Current Price $1.58
Current
$1.58
Target
$41.03
$36.60 $41.03 avg $68.97
Scenario Analysis
Bear Case
$36.60
2,216.5%
Low target
Base Case
$41.03
+2,496.8%
Avg target
Bull Case
$68.97
+4,265.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.50
-64.9% from high
52-Week Low
$0.72
+119.7% from low
Target vs 52W High
$41.03
+811.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.1%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%